Low Levels of Cell-Free Circulating miR-361-3p and miR-625* as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors

The high mortality rate of lung cancer patients is mainly due to the late stage at which lung cancer is diagnosed. For effective cancer prevention programs and early diagnosis, better blood-based markers are needed. Hence, blood-based microarray profiling of microRNA (miR) expression was performed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, Carina, Stückrath, Isabel, Pantel, Klaus, Izbicki, Jakob R., Tachezy, Michael, Schwarzenbach, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366929/
https://www.ncbi.nlm.nih.gov/pubmed/22675530
http://dx.doi.org/10.1371/journal.pone.0038248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366929/
https://www.ncbi.nlm.nih.gov/pubmed/22675530
http://dx.doi.org/10.1371/journal.pone.0038248

Ejemplares similares